The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Carter Kenneth C since year 2005.
The trader's CIK number is 1332217.
At the time of this reporting, Carter Kenneth C is the President and CEO of Avalon Pharmaceuticals Inc .
(stock ticker symbol AVRX).
See this page for all insider trading activities at Avalon Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2008-01-17||AVRX||Avalon Pharmaceuticals Inc||Sale||2,032||2.56||5,191|
|2008-01-23||AVRX||Avalon Pharmaceuticals Inc||Buy||4,832||2.55||12,307|
|2006-08-30||AVRX||Avalon Pharmaceuticals Inc||Buy||3,000||2.99||8,970|
|2006-08-22||AVRX||Avalon Pharmaceuticals Inc||Buy||2,000||3.27||6,540|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Carter Kenneth C (President and CEO of Avalon Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.